These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 17650352)
1. Nebulizer efficiency: modeling versus in vitro testing. Dennis JH Respir Care; 2007 Aug; 52(8):984-8. PubMed ID: 17650352 [No Abstract] [Full Text] [Related]
2. Standardization issues: in vitro assessment of nebulizer performance. Dennis JH Respir Care; 2002 Dec; 47(12):1445-55; discussion 1455-8. PubMed ID: 12467502 [TBL] [Abstract][Full Text] [Related]
3. A new system for understanding nebulizer performance. Chatburn RL; McPeck M Respir Care; 2007 Aug; 52(8):1037-50. PubMed ID: 17650361 [TBL] [Abstract][Full Text] [Related]
4. Influence of realistic airflow rate on aerosol generation by nebulizers. Vecellio L; Kippax P; Rouquette S; Diot P Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494 [TBL] [Abstract][Full Text] [Related]
5. A method for increasing jet nebulizer delivery efficiency for aerosol drug delivery in ventilated newborns: an in vitro study. Quong MC; Thébaud B; Finlay WH Respir Care; 2006 Nov; 51(11):1244-50. PubMed ID: 17067406 [TBL] [Abstract][Full Text] [Related]
6. Aerosol therapy: regimen and device compliance in daily practice. Everard ML Paediatr Respir Rev; 2006; 7 Suppl 1():S80-2. PubMed ID: 16798605 [No Abstract] [Full Text] [Related]
7. Development and evaluation of a pulsed nebulizer with predictable dosing characteristics. Miller NC; Morken MA; Schultz RK J Aerosol Med; 1995; 8(4):357-62. PubMed ID: 10157894 [TBL] [Abstract][Full Text] [Related]
8. Modeling of aerosol deposition with interface devices. Finlay WH; Martin AR J Aerosol Med; 2007; 20 Suppl 1():S19-26; discussion S27-8. PubMed ID: 17411402 [TBL] [Abstract][Full Text] [Related]
9. Aerosolized iloprost customized for the critically ill. Harris KW; O'Riordan TG; Smaldone GC Respir Care; 2007 Nov; 52(11):1507-9. PubMed ID: 17971254 [TBL] [Abstract][Full Text] [Related]
10. [Better routines in connection with nebulizer therapy are required. New European guidelines serve as a guidance in Swedish health care, too]. Lannefors L; Persson O; Löfdahl CG Lakartidningen; 2002 Oct; 99(42):4176-80. PubMed ID: 12448299 [No Abstract] [Full Text] [Related]
11. United States Pharmacopeia recommendations for the testing of inhalers. Byron PR J Aerosol Med; 1998; 11 Suppl 1():S11-12. PubMed ID: 10180721 [No Abstract] [Full Text] [Related]
12. Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Lin HL; Restrepo RD; Gardenhire DS; Rau JL Respir Care; 2007 Aug; 52(8):1021-6. PubMed ID: 17650358 [TBL] [Abstract][Full Text] [Related]
15. Regarding the development and practice of cascade impaction testing, including a mass balance failure investigation tree. Mitchell JP; J Aerosol Med; 2003; 16(4):433. PubMed ID: 14977433 [No Abstract] [Full Text] [Related]
16. New guidelines conclude all aerosol therapy devices equally effective. School Nurse News; 2005 May; 22(3):9-10. PubMed ID: 15934537 [No Abstract] [Full Text] [Related]
17. Paper spacer device for inhalers. Elder NC Am Fam Physician; 1991 Aug; 44(2):398, 400. PubMed ID: 1858599 [No Abstract] [Full Text] [Related]